BlackRock Fund Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $79.3M | Sell |
5,984,758
-461,821
| -7% | -$6.12M | 0.01% | 1378 |
|
|
2016
Q3 | $153M | Buy |
6,446,579
+649,256
| +11% | +$15.4M | 0.03% | 733 |
|
|
2016
Q2 | $167M | Buy |
5,797,323
+185,241
| +3% | +$5.34M | 0.04% | 608 |
|
|
2016
Q1 | $180M | Buy |
5,612,082
+128,019
| +2% | +$4.1M | 0.04% | 541 |
|
|
2015
Q4 | $234M | Sell |
5,484,063
-117,670
| -2% | -$5.03M | 0.05% | 402 |
|
|
2015
Q3 | $197M | Buy |
5,601,733
+221,157
| +4% | +$7.79M | 0.05% | 437 |
|
|
2015
Q2 | $247M | Buy |
5,380,576
+72,986
| +1% | +$3.35M | 0.06% | 374 |
|
|
2015
Q1 | $249M | Buy |
5,307,590
+289,794
| +6% | +$13.6M | 0.06% | 377 |
|
|
2014
Q4 | $159M | Buy |
5,017,796
+319,336
| +7% | +$10.1M | 0.04% | 593 |
|
|
2014
Q3 | $111M | Buy |
4,698,460
+16,372
| +0.3% | +$388K | 0.03% | 755 |
|
|
2014
Q2 | $140M | Sell |
4,682,088
-265,207
| -5% | -$7.95M | 0.04% | 622 |
|
|
2014
Q1 | $131M | Buy |
4,947,295
+161,709
| +3% | +$4.27M | 0.04% | 642 |
|
|
2013
Q4 | $120M | Buy |
4,785,586
+195,642
| +4% | +$4.92M | 0.04% | 697 |
|
|
2013
Q3 | $94M | Buy |
4,589,944
+437,784
| +11% | +$8.96M | 0.03% | 800 |
|
|
2013
Q2 | $82.8M | Buy |
+4,152,160
| New | +$82.8M | 0.03% | 798 |
|